BRTX Wutah pendapatan kuartal marang kuartal BioRestorative

BRTX (BioRestorative) - tandha merek perusahaan

Quarterly revenue growth rates reflect current dynamics, with the value standing at -7.30. BioRestorative Therapies (BRTX) relies on ThermoCell to combat obesity and back pain. The company drives development through university partnerships and patent acquisitions; however, BioRestorative Therapies (BRTX) faces a capital shortage and a lack of sales due to clinical trial expenses.

BioRestorative Therapies (BRTX) - Owah-owahan dodolan kuartal marang kuartal saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan BioRestorative (BRTX)

- rega saham lan target rega konsensus:
- statistik dhuwit lan arus kas:
Analisis kabeh metrik perusahaan:biorestorative.com - BRTX
Produk seri BioRestorative Therapies Inc

This indicator measures the percentage dynamics of quarterly commercial revenues relative to the preceding period, allowing for an assessment of business scaling rates through daily calculations. The trend analysis of quarterly revenue changes confirms the financial instability of BioRestorative Therapies (BRTX), as the lack of market pricing power and the current FDA clinical trial stage render this metric effectively zero.